Prevalence of Uropathogenic E. Coli, Antimicrobial Susceptibility Profiles and Carriage of Extended-Spectrum Beta-Lactamases Genes at Mama Lucy Hospital, Kenya
DOI:
https://doi.org/10.47604/gjhs.3153Keywords:
Urinary Tract Infections, Uropathogenic Escherichia Coli, Antibiotic Resistance, Extended Spectrum Beta-LactamasesAbstract
Purpose: Urinary tract infection (UTI) is a common bacterial infection affecting millions worldwide. Escherichia coli (E. coli) is the most prevalent causative agent of UTIs. This study aimed to determine the prevalence, antimicrobial susceptibility profiles and carriage of ESβL resistance genes among uropathogenic E. coli recovered from adults at Mama Lucy Hospital.
Methodology: A cross-sectional study was conducted. A purposive method was used to obtain 347 urine samples from patients who presented with symptoms suggestive of UTI and were cultured for E. coli using cysteine lactose electrolyte-deficient agar and eosin methylene blue agar. The collected urine samples were also subjected to dipstick analysis and microscopy. Questionnaires were used to collect sociodemographic data and possible risk factors for urinary tract infections. The recovered isolates were identified using conventional biochemical tests. Antimicrobial susceptibility profiles were determined using the Kirby diffusion disc method. The occurrence of ESβLs, including TEM, OXA, SHV, and CTX-M, was determined by polymerase chain reaction (PCR).
Findings: The overall prevalence rate of UTIs was 23.7%, whereas the E. coli prevalence rate was 13.3%. The isolates presented high levels of resistance to trimethoprim-sulfamethoxazole (81.3%), amoxicillin-clavulanic acid (66.7%), ciprofloxacin (62.5%), tetracycline (60.4%), ceftriaxone (54.2%), and cefoxitin (54.2%), whereas they were more susceptible to meropenem (14.6%), chloramphenicol (12.5%), and nitrofurantoin (8.3%). A total of 25 of the 46 E. coli isolates were screened for ESβL genes. TEM was the most common gene21/25 (84%), SHV12/25 (48%), OXA 7/25 (28%), and CTX-M 18/25 (66.1%), which indicates a high frequency of β-lactamase gene production among UTIs causing E. coli.
Unique Contribution to Theory, Practice and Policy: Based on these findings, current treatment guidelines should be revised to prevent increasing antimicrobial resistance through continuous surveillance, screening for extended-spectrum beta-lactamase genes, routine culture and antibiotic sensitivity testing. Additionally, the prevalence of UTIs should be continuously monitored to monitor trends that form a basis for preventive and treatment guidelines, such as policy development and prudent use of antibiotics, to reduce the increasing UTI burden in the population.
Downloads
References
Abate, D., Marami, D., & Letta, S. (2020). Prevalence, Antimicrobial Susceptibility Pattern, and Associated Factors of Urinary Tract Infections among Pregnant and Nonpregnant Women at Public Health Facilities, Harar, Eastern Ethiopia: A Comparative Cross‐Sectional Study. Canadian Journal of Infectious Diseases and Medical Microbiology, 2020(1), 9356865.
Abrar, S., Hussain, S., Khan, R. A., Ul Ain, N., Haider, H., & Riaz, S. (2018). Prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae: first systematic meta-analysis report from Pakistan. Antimicrobial Resistance & Infection Control, 7, 1–11.
Al-Badr, A., & Al-Shaikh, G. (2013). Recurrent urinary tract infections management in women: a review. Sultan Qaboos University Medical Journal, 13(3), 359.
Alhashash, F. A. (2015). Populations of Escherichia coli in clinical samples of Urinary Tract Infections and Bacteraemia. Nottingham Trent University (United Kingdom).
Bauer, A. W. (1996). Antibiotic susceptibility testing by a standardized single disc method. Am. J. of Clinc. Path., 45, 149–158.
Bradford, P. A. (2001). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clinical Microbiology Reviews, 14(4), 933–951.
Bush, K., & Bradford, P. A. (2016). β-Lactams and β-lactamase inhibitors: an overview. Cold Spring Harbor Perspectives in Medicine, 6(8), a025247.
Dashti, A. A., Jadaon, M. M., Abdulsamad, A. M., & Dashti, H. M. (2009). Heat treatment of bacteria: a simple DNA extraction method for molecular techniques. Kuwait Med J, 41(2), 117–122.
Dhillon, R. H.-P., & Clark, J. (2012). ESBLs: a clear and present danger? Critical Care Research and Practice, 2012(1), 625170.
Flores-Mireles, A. L., Walker, J. N., Caparon, M., & Hultgren, S. J. (2015). Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature Reviews. Microbiology, 13(5), 269–284. https://doi.org/10.1038/nrmicro3432
Foxman, B. (2002). Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. The American Journal of Medicine, 113(1), 5–13.
Foxman, B., & Brown, P. (2003). Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infectious Disease Clinics, 17(2), 227–241.
Haque, R., Akter, M. L., & Salam, M. A. (2015). Prevalence and susceptibility of uropathogens: a recent report from a teaching hospital in Bangladesh. BMC Research Notes, 8, 1–5.
Hryniewicz, K., Szczypa, K., Sulikowska, A., Jankowski, K., Betlejewska, K., & Hryniewicz, W. (2001). Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. Journal of Antimicrobial Chemotherapy, 47(6), 773–780.
Ikram, R., Psutka, R., Carter, A., & Priest, P. (2015). An outbreak of multi-drug resistant Escherichia coli urinary tract infection in an elderly population: a case-control study of risk factors. BMC Infectious Diseases, 15, 1–7.
Joya, M., Aalemi, A. K., & Baryali, A. T. (2022). Prevalence and antibiotic susceptibility of the common bacterial uropathogen among UTI patients in French Medical Institute for Children. Infection and Drug Resistance, 4291–4297.
Katongole, P., Nalubega, F., Florence, N. C., Asiimwe, B., & Andia, I. (2020). Biofilm formation, antimicrobial susceptibility and virulence genes of Uropathogenic Escherichia coli isolated from clinical isolates in Uganda. BMC Infectious Diseases, 20, 1–6.
Kot, B. (2019). Antibiotic resistance among uropathogenic. Polish Journal of Microbiology, 68(4), 403–415.
Llor, C., & Bjerrum, L. (2014). Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Therapeutic Advances in Drug Safety, 5(6), 229–241.
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., & Olsson-Liljequist, B. (2012). Multidrug-resistant, extensively drug-resistant and pan drug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection, 18(3), 268–281.
Maina, J., Mwaniki, J., Mwiti, F., Kiiru, S., Katana, J., Wanja, F., Mukaya, J., Khasabuli, O., Asiimwe, B., & Gillespie, S. (2023). Evaluation of the diagnostic performance of the urine dipstick test for the detection of urinary tract infections in patients treated in Kenyan hospitals. Access Microbiology, 5(6), 000483-v3.
Maingi, E., Nyerere, A., & Makobe, C. (2023). Phenotypic and Genotypic Characterization of Extended Spectrum Beta-Lactamases Producing Bacteria Causing Urinary Tract Infections among Expectant Women Attending Antenatal Clinic at Ruiru Sub County Hospital, Kenya. Advances in Microbiology, 13(12), 571–587.
Majumder, M. M. I., Mahadi, A. R., Ahmed, T., Ahmed, M., Uddin, M. N., & Alam, M. Z. (2022). Antibiotic resistance pattern of microorganisms causing urinary tract infection: a 10-year comparative analysis in a tertiary care hospital of Bangladesh. Antimicrobial Resistance & Infection Control, 11(1), 156.
Makeri, D., Dilli, P. P., Nyaketcho, D., & Pius, T. (2023). Prevalence of Urinary Tract Infections in Uganda: A Systematic Review and Meta-Analysis. Open Access Library Journal, 10(8), 1–15.
Medina, M., & Castillo-Pino, E. (2019). An introduction to the epidemiology and burden of urinary tract infections. Therapeutic Advances in Urology, 11, 1756287219832172.
Mehrgan, H., & Rahbar, M. (2008). Prevalence of extended-spectrum β-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran. International Journal of Antimicrobial Agents, 31(2), 147–151.
Mitsan, O., Okwu, M. U., Osareniro, O. E., & James, A. (2020). Distribution of TEM, SHV, OXA AND CTX-M Genes among ESBL-producing E. coli isolates from patients with urinary tract infections. Sokoto Journal of Medical Laboratory Science, 5(1).
Odoki, M., Almustapha Aliero, A., Tibyangye, J., Nyabayo Maniga, J., Wampande, E., Drago Kato, C., Agwu, E., & Bazira, J. (2019). Prevalence of bacterial urinary tract infections and associated factors among patients attending hospitals in Bushenyi district, Uganda. International Journal of Microbiology, 2019(1), 4246780.
Odongo, I., Ssemambo, R., & Kungu, J. M. (2020). Prevalence of Escherichia coli and its antimicrobial susceptibility profiles among patients with UTI at Mulago Hospital, Kampala, Uganda. Interdisciplinary Perspectives on Infectious Diseases, 2020(1), 8042540.
Omwenga, E. O., Simba, S. M., & Musyoki, S. K. (2022). Prevalence of E. coli as a causative agent of urinary tract infections and its drug susceptibility patterns among pregnant mothers seeking medicare at Kisii Teaching and Referral Hospital, Kenya.
Onyango, H. A., Ngugi, C., Maina, J., & Kiiru, J. (2018). Urinary tract infection among pregnant women at Pumwani Maternity Hospital, Nairobi, Kenya: bacterial etiologic agents, antimicrobial susceptibility profiles and associated risk factors. Advances in Microbiology, 8(03), 175.
Pandit, R., Awal, B., Shrestha, S. S., Joshi, G., Rijal, B. P., & Parajuli, N. P. (2020). Extended‐spectrum β‐Lactamase (ESBL) genotypes among multidrug‐resistant uropathogenic Escherichia coli clinical isolates from a Teaching Hospital in Nepal. Interdisciplinary Perspectives on Infectious Diseases, 2020(1), 6525826.
Paterson, D. L., & Bonomo, R. A. (2005). Extended-spectrum β-lactamases: a clinical update. Clinical Microbiology Reviews, 18(4), 657–686.
Picozzi, S. C. M., Casellato, S., Rossini, M., Paola, G., Tejada, M., Costa, E., & Carmignani, L. (2014). Extended-spectrum beta-lactamase-positive Escherichia coli causing complicated upper urinary tract infection: Urologist should act in time. Urology Annals, 6(2), 107–112.
Rahal, J. J. (2009). Antimicrobial resistance among and therapeutic options against gram-negative pathogens. Clinical Infectious Diseases, 49(Supplement_1), S4–S10.
Rahman, M. S., Garg, R., Singh, V. A., & Biswas, D. (2018). Antibiotic susceptibility profile and extended-spectrum β-lactamases production by uropathogenic Escherichia coli from tertiary care hospital of rural settings. Int J Res Med Sci, 6(12), 4022–4027.
Rawat, D., & Nair, D. (2010). Extended-spectrum β-lactamases in Gram Negative Bacteria. Journal of Global Infectious Diseases, 2(3), 263–274.
Scholes, D., Hooton, T. M., Roberts, P. L., Stapleton, A. E., Gupta, K., & Stamm, W. E. (2000). Risk factors for recurrent urinary tract infection in young women. The Journal of Infectious Diseases, 182(4), 1177–1182.
Serrano, G. L., & Penuliar, G. M. (n.d.). Uropathogenic Escherichia coli from pregnant women with urinary.
Shaikh, S., Fatima, J., Shakil, S., Rizvi, S. M. D., & Kamal, M. A. (2015). Antibiotic resistance and extended-spectrum beta-lactamases: Types, epidemiology and treatment. Saudi Journal of Biological Sciences, 22(1), 90–101.
Silago, V., Moremi, N., Mtebe, M., Komba, E., Masoud, S., Mgaya, F. X., Mirambo, M. M., Nyawale, H. A., Mshana, S. E., & Matee, M. I. (2022). Multidrug-resistant uropathogens causing community-acquired urinary tract infections among patients attending health facilities in Mwanza and Dar es Salaam, Tanzania. Antibiotics, 11(12), 1718.
Tarek, A., El-Mahdy, T. S., Abdelrahman, A. A., & Abdalla, S. (2024). Uropathogenic Escherichia coli Virulence and Antibiotic Resistance. Records of Pharmaceutical and Biomedical Sciences, 8(2), 87–95.
Tony Mazzulli, M. D. (2012). Diagnosis and management of simple and complicated urinary tract infections (UTIs). Can J Urol, 19(1), 42–48.
Tripathi, N., & Sapra, A. (2020). 2020. Gram Staining.
Uwaezuoke, S. N. (2016). The prevalence of urinary tract infection in children with severe acute malnutrition: a narrative review. Pediatric Health, Medicine and Therapeutics, 7, 121–127. https://doi.org/10.2147/PHMT.S107421
Wanja, F., Ngugi, C., Omwenga, E., Maina, J., & Kiiru, J. (2021). Urinary Tract Infection among Adults Seeking Medicare at Kiambu Level 5 Hospital, Kenya: Prevalence, Diversity, Antimicrobial Susceptibility Profiles and Possible Risk Factors. Advances in Microbiology, 11(08), 360–383. https://doi.org/10.4236/aim.2021.118028
Zagaglia, C., Ammendolia, M. G., Maurizi, L., Nicoletti, M., & Longhi, C. (2022). Urinary Tract Infections Caused by Uropathogenic Escherichia coli Strains-New Strategies for an Old Pathogen. Microorganisms, 10(7). https://doi.org/10.3390/microorganisms1007
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Shirleen Chelangat, Caroline Ngugi, Edinah Song’oro, John Njeru Mwaniki
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
